CN103599104B - Application of Caesanines D in drug for treating or preventing dental ulcer - Google Patents
Application of Caesanines D in drug for treating or preventing dental ulcer Download PDFInfo
- Publication number
- CN103599104B CN103599104B CN201310618334.0A CN201310618334A CN103599104B CN 103599104 B CN103599104 B CN 103599104B CN 201310618334 A CN201310618334 A CN 201310618334A CN 103599104 B CN103599104 B CN 103599104B
- Authority
- CN
- China
- Prior art keywords
- caesanines
- day
- ulcer
- administration
- dental ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 208000025865 Ulcer Diseases 0.000 title abstract description 18
- 231100000397 ulcer Toxicity 0.000 title abstract description 18
- 229940079593 drug Drugs 0.000 title abstract description 5
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 description 9
- 208000020670 canker sore Diseases 0.000 description 7
- 208000007117 Oral Ulcer Diseases 0.000 description 6
- 208000002399 aphthous stomatitis Diseases 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 239000006189 buccal tablet Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000015162 Caesalpinia sappan Nutrition 0.000 description 3
- 244000306301 Caesalpinia sappan Species 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229940046011 buccal tablet Drugs 0.000 description 3
- 229930002147 cassane Natural products 0.000 description 3
- 229930004069 diterpene Natural products 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010028034 Mouth ulceration Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- The application of 1.Caesanines D in preparation treatment stomatocace medicine, described Compound C aesanines D structure is as shown in formula I:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310618334.0A CN103599104B (en) | 2013-11-28 | 2013-11-28 | Application of Caesanines D in drug for treating or preventing dental ulcer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310618334.0A CN103599104B (en) | 2013-11-28 | 2013-11-28 | Application of Caesanines D in drug for treating or preventing dental ulcer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103599104A CN103599104A (en) | 2014-02-26 |
CN103599104B true CN103599104B (en) | 2015-06-17 |
Family
ID=50117413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310618334.0A Active CN103599104B (en) | 2013-11-28 | 2013-11-28 | Application of Caesanines D in drug for treating or preventing dental ulcer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103599104B (en) |
-
2013
- 2013-11-28 CN CN201310618334.0A patent/CN103599104B/en active Active
Non-Patent Citations (1)
Title |
---|
Caesanines A-D, New Cassane Diterpenes with Unprecedented N Bridge from Caesalpinia sappan;Zhang Jingyu et al.,;《Organic Letters》;20130920;第15卷(第18期);p.4726-4729 * |
Also Published As
Publication number | Publication date |
---|---|
CN103599104A (en) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768308B (en) | A kind of pharmaceutical composition that is used for the treatment of the infection of the upper respiratory tract and preparation method thereof | |
CN101564458A (en) | Application of Chinese medicinal composition in preparing medicament for treating bronchitis | |
CN103585147B (en) | Application of Nitrosporeusines A in preparation of oral ulcer treatment or prevention medicines | |
CN103462951B (en) | Application of scopariusins in preparation of medicine treating or preventing canker sore | |
CN103599104B (en) | Application of Caesanines D in drug for treating or preventing dental ulcer | |
CN103505464B (en) | The application of Phyllanthoid A in preparation treatment or preventing canker sore medicine | |
CN103479624B (en) | Application of Racemosins A in preparation of oral ulcer treatment or prevention medicines | |
CN103356653B (en) | The application of Chukrasone A in preparation treatment or preventing canker sore medicine | |
CN103638005B (en) | The application of Hippolachnin A in treatment or preventing canker sore medicine | |
CN107501435A (en) | The extracting method of pachymaran and its application | |
CN106344555A (en) | Application of Fistulains B in drugs for dental ulcer prevention or treatment | |
CN105147676A (en) | Medicine for preventing or treating dental ulcer | |
CN105287543A (en) | Application of strynuxlines B to prepare medicines treating or preventing oral ulcer | |
CN105412109A (en) | Application of Biscarpamontamine B in preparing drugs for treating or preventing dental ulcers | |
CN105434428A (en) | Applications of Volvalerelactones B in preparing drugs used for treating or preventing dental ulcer | |
CN102988382B (en) | Application of Houttuynoid C for preparing medicine for treating or preventing dental ulcer | |
CN105232531A (en) | Application of Penifulvin A in preparing drugs for treating or preventing dental ulcers | |
CN103263423A (en) | Application of myriberine A in preparation of medicaments for treating or preventing canker sores | |
CN102872056B (en) | Application of Gypensapogenin A to preparing drugs for treating or preventing canker sores | |
CN106491621A (en) | Friedolanostanes is preparing treatment or the application in preventing canker sore medicine | |
CN103462998A (en) | Application of Neonectrolide A in preparing medicament for treating or preventing dental ulcer | |
CN102872060B (en) | Application of Gypensapogenin B to preparing drugs for treating or preventing canker sores | |
CN106265638A (en) | Linderolide H application in preparation treatment or preventing canker sore medicine | |
CN109692255A (en) | A kind of Chinese medicine composition and its preparation method and application for treating acute tracheobronchitis | |
CN103381160A (en) | Applications of Chukrasone B in medicines used for curing or preventing oral ulcer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Song Xiuxiang Inventor after: Zang Xiaoguo Inventor after: Li Aifang Inventor after: Li Qiang Inventor before: Li Qiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI QIANG TO: SONG XIUXIANG ZANG XIAOGUO LI AIFANG LI QIANG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170930 Address after: 226500 Jiangsu city of Nantong province Rugao City, Dong Chen Zhen Hong Bridge neighborhood 4 groups Patentee after: Rugao Chengdong hospital Address before: 266000 Shandong province Qingdao City Red Road No. 31 North Building 201 Patentee before: Li Qiang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191209 Address after: Room 306, building 3, business center, No. 82, Huayuan West Road, Chuzhou, Anhui Patentee after: CHUZHOU TIANSHUN PRODUCTIVITY PROMOTION Co.,Ltd. Address before: 226500 Jiangsu city of Nantong province Rugao City, Dong Chen Zhen Hong Bridge neighborhood 4 groups Patentee before: Rugao Chengdong hospital |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221213 Address after: 276000 No. 95, Huaxia Road, economic and Technological Development Zone, Linyi City, Shandong Province Patentee after: SHANDONG TIANCHENG STEEL STRUCTURE Co.,Ltd. Address before: 239000 incubation workshop, room 306, building 3, entrepreneurship center, No.82 Huayuan West Road, Chuzhou City, Anhui Province Patentee before: CHUZHOU TIANSHUN PRODUCTIVITY PROMOTION Co.,Ltd. |